you are here: HomeNewsEmkay
emkay
Jump to
460 Results Found
  • Power Gird Corporation Q2 PAT seen up 11.2% YoY to Rs. 2,568.5 cr: Emkay Oct 14, 2019 05:12 PM IST

    Power Gird Corporation Q2 PAT seen up 11.2% YoY to Rs. 2,568.5 cr: Emkay

    Net Sales are expected to increase by 5.8 percent Y-o-Y (up 0.8 percent Q-o-Q) to Rs. 8,759.8 crore, according to Emkay.

  • NHPC Q2 PAT seen up 1.4% YoY to Rs. 1,220 cr: Emkay Oct 14, 2019 05:09 PM IST

    NHPC Q2 PAT seen up 1.4% YoY to Rs. 1,220 cr: Emkay

    Net Sales are expected to decrease by 0.7 percent Y-o-Y (up 2.3 percent Q-o-Q) to Rs. 2,476.8 crore, according to Emkay.

  • JSW Energy Q2 PAT may dip 17.4% YoY to Rs. 249.6 cr: Emkay Oct 14, 2019 05:06 PM IST

    JSW Energy Q2 PAT may dip 17.4% YoY to Rs. 249.6 cr: Emkay

    Net Sales are expected to decrease by 8.2 percent Y-o-Y (down 7.5 percent Q-o-Q) to Rs. 2,231.7 crore, according to Emkay.

  • Gujarat Industries Power Q2 PAT may dip 5.5% YoY to Rs. 64.4 cr: Emkay Oct 14, 2019 05:03 PM IST

    Gujarat Industries Power Q2 PAT may dip 5.5% YoY to Rs. 64.4 cr: Emkay

    Net Sales are expected to decrease by 12.1 percent Y-o-Y (down 10.3 percent Q-o-Q) to Rs. 317.4 crore, according to Emkay.

  • CESC Q2 PAT seen up 3.6% YoY to Rs. 280.8 cr: Emkay Oct 14, 2019 04:59 PM IST

    CESC Q2 PAT seen up 3.6% YoY to Rs. 280.8 cr: Emkay

    Net Sales are expected to increase by 6.5 percent Y-o-Y (up 0.2 percent Q-o-Q) to Rs. 2,364.7 crore, according to Emkay.

  • Torrent Pharma Q2 PAT seen up 8% YoY to Rs. 220.3 cr: Emkay Oct 14, 2019 04:15 PM IST

    Torrent Pharma Q2 PAT seen up 8% YoY to Rs. 220.3 cr: Emkay

    Net Sales are expected to increase by 9.4 percent Y-o-Y (up 2.5 percent Q-o-Q) to Rs. 2,073 crore, according to Emkay.

  • Ipca Labs Q2 PAT seen up 34% YoY to Rs. 160.2 cr: Emkay Oct 14, 2019 04:12 PM IST

    Ipca Labs Q2 PAT seen up 34% YoY to Rs. 160.2 cr: Emkay

    Net Sales are expected to increase by 12.8 percent Y-o-Y (up 11.3 percent Q-o-Q) to Rs. 1,125.4 crore, according to Emkay.

  • Granules Q2 PAT seen up 19% YoY to Rs. 72 cr: Emkay Oct 14, 2019 04:09 PM IST

    Granules Q2 PAT seen up 19% YoY to Rs. 72 cr: Emkay

    Net Sales are expected to increase by 13 percent Y-o-Y (up 10.3 percent Q-o-Q) to Rs. 656.4 crore, according to Emkay.

  • Glenmark Q2 PAT may dip 46% YoY to Rs. 132.8 cr: Emkay Oct 14, 2019 04:07 PM IST

    Glenmark Q2 PAT may dip 46% YoY to Rs. 132.8 cr: Emkay

    Net Sales are expected to increase by 2.4 percent Y-o-Y (up 13.8 percent Q-o-Q) to Rs. 2,642.7 crore, according to Emkay.

  • Dr. Reddy’s Q2 PAT may dip 10% YoY to Rs. 455.9 cr: Emkay Oct 14, 2019 03:56 PM IST

    Dr. Reddy’s Q2 PAT may dip 10% YoY to Rs. 455.9 cr: Emkay

    Net Sales are expected to increase by 9.7 percent Y-o-Y (up 8.4 percent Q-o-Q) to Rs. 4,167.1 crore, according to Emkay.

  • Divi’s Q2 PAT may dip 9% YoY to Rs. 363.7 cr: Emkay Oct 14, 2019 03:53 PM IST

    Divi’s Q2 PAT may dip 9% YoY to Rs. 363.7 cr: Emkay

    Net Sales are expected to increase by 5.4 percent Y-o-Y (up 16.5 percent Q-o-Q) to Rs. 1,354.7 crore, according to Emkay.

  • Cadila Healthcare Q2 PAT may dip 23% YoY to Rs. 321.5 cr: Emkay Oct 14, 2019 03:49 PM IST

    Cadila Healthcare Q2 PAT may dip 23% YoY to Rs. 321.5 cr: Emkay

    Net Sales are expected to increase by 17.4 percent Y-o-Y (down 0.6 percent Q-o-Q) to Rs. 3,475.2 crore, according to Emkay.

  • Aurobindo Q2 PAT seen up 6% YoY to Rs. 675.1 cr: Emkay Oct 14, 2019 03:47 PM IST

    Aurobindo Q2 PAT seen up 6% YoY to Rs. 675.1 cr: Emkay

    Net Sales are expected to increase by 18.8 percent Y-o-Y (up 3.7 percent Q-o-Q) to Rs. 5,645.7 crore, according to Emkay.

  • Cipla Q2 PAT seen up 17% YoY to Rs. 442.8 cr: Emkay Oct 14, 2019 03:44 PM IST

    Cipla Q2 PAT seen up 17% YoY to Rs. 442.8 cr: Emkay

    Net Sales are expected to increase by 7.4 percent Y-o-Y (up 8 percent Q-o-Q) to Rs. 4,308.8 crore, according to Emkay.

  • Lupin Q2 PAT may dip 22% YoY to Rs. 206.5 cr: Emkay Oct 14, 2019 03:41 PM IST

    Lupin Q2 PAT may dip 22% YoY to Rs. 206.5 cr: Emkay

    Net Sales are expected to increase by 6.2 percent Y-o-Y (down 5.1 percent Q-o-Q) to Rs. 4,195.2 crore, according to Emkay.

  • Sun Pharma Q2 PAT seen up 12% YoY to Rs. 1,114.8 cr: Emkay Oct 14, 2019 03:35 PM IST

    Sun Pharma Q2 PAT seen up 12% YoY to Rs. 1,114.8 cr: Emkay

    Net Sales are expected to increase by 15.2 percent Y-o-Y (down 4.6 percent Q-o-Q) to Rs. 7,988.9 crore, according to Emkay.

  • Rallis India Q2 PAT seen up 8.8% YoY to Rs. 92.8 cr: Emkay Oct 11, 2019 05:34 PM IST

    Rallis India Q2 PAT seen up 8.8% YoY to Rs. 92.8 cr: Emkay

    Net Sales are expected to increase by 10 percent Y-o-Y (up 15.4 percent Q-o-Q) to Rs. 719.2 crore, according to Emkay.

  • PI Industries Q2 PAT seen up 53.4% YoY to Rs. 112.4 cr: Emkay Oct 11, 2019 05:32 PM IST

    PI Industries Q2 PAT seen up 53.4% YoY to Rs. 112.4 cr: Emkay

    Net Sales are expected to increase by 16.6 percent Y-o-Y (up 11.8 percent Q-o-Q) to Rs. 843 crore, according to Emkay.

  • Dhanuka Agritech Q2 PAT may dip 8.1% YoY to Rs. 50.6 cr: Emkay Oct 11, 2019 05:30 PM IST

    Dhanuka Agritech Q2 PAT may dip 8.1% YoY to Rs. 50.6 cr: Emkay

    Net Sales are expected to increase by 6 percent Y-o-Y (up 85.6 percent Q-o-Q) to Rs. 406.4 crore, according to Emkay.

  • Coromandel International Q2 PAT may dip 3.1% YoY to Rs. 374.4 cr: Emkay Oct 11, 2019 05:28 PM IST

    Coromandel International Q2 PAT may dip 3.1% YoY to Rs. 374.4 cr: Emkay

    Net Sales are expected to increase by 5 percent Y-o-Y (up 146.8 percent Q-o-Q) to Rs. 5,258.7 crore, according to Emkay.

  • Subscribe to Music Broadcast Ltd: Emkay Mar 06, 2017 12:13 PM IST

    Subscribe to Music Broadcast Ltd: Emkay

    Emkay has come out with its report on Music Broadcast Ltd. The research firm has recommended to "Subscribe " the IPO in its research report as on March 02 , 2017.

  • Buy Shoppers Stop; target of Rs 380: Emkay Feb 11, 2017 02:44 PM IST

    Buy Shoppers Stop; target of Rs 380: Emkay

    Emkay is bullish on Shoppers Stop has recommended buy rating on the stock with a target price of Rs 380 in its research report dated February 02, 2017.

  • Buy, sell, hold: 4 stocks analysts are watching Feb 03, 2017 09:34 AM IST

    Buy, sell, hold: 4 stocks analysts are watching

    CLSA says special court verdict on former Telecom Minister Dayanidhi Maran and his brother & head of the company Kalanidhi Maran, in Aircel-Maxis case, ended long-standing legal overhang on the company. The brokerage house has upgraded the stock to buy from sell and raised target price to Rs 661 from Rs 438.

  • RBL Bank IPO opens: Should you subscribe or avoid? Aug 19, 2016 08:45 AM IST

    RBL Bank IPO opens: Should you subscribe or avoid?

    With a bullish stance, Prabhudas Lilladher says that the bank has stayed away from stressed sector lending like steel/power/infra which has helped it to maintain its asset quality at better levels compared to peers despite 60 percent loans in corporate & MSME.

  • Supplementary grants, public spending a sign of reflation: Emkay Aug 09, 2016 09:30 PM IST

    Supplementary grants, public spending a sign of reflation: Emkay

    Reinforcement of rural demand along with increase in pays of government employees and accommodative monetary stance embody the strengthening reflationary impulses, says a note by equity research house Emkay which expects the trend to culminate into a bump up in consumption demand.

Sections